EMBO Molecular Medicine (Jan 2021)

Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis

  • Katerina Placek,
  • Michael Benatar,
  • Joanne Wuu,
  • Evadnie Rampersaud,
  • Laura Hennessy,
  • Vivianna M Van Deerlin,
  • Murray Grossman,
  • David J Irwin,
  • Lauren Elman,
  • Leo McCluskey,
  • Colin Quinn,
  • Volkan Granit,
  • Jeffrey M Statland,
  • Ted M Burns,
  • John Ravits,
  • Andrea Swenson,
  • Jon Katz,
  • Erik P Pioro,
  • Carlayne Jackson,
  • James Caress,
  • Yuen So,
  • Samuel Maiser,
  • David Walk,
  • Edward B Lee,
  • John Q Trojanowski,
  • Philip Cook,
  • James Gee,
  • Jin Sha,
  • Adam C Naj,
  • Rosa Rademakers,
  • The CReATe Consortium,
  • Wenan Chen,
  • Gang Wu,
  • J Paul Taylor,
  • Corey T McMillan

DOI
https://doi.org/10.15252/emmm.202012595
Journal volume & issue
Vol. 13, no. 1
pp. n/a – n/a

Abstract

Read online

Abstract Amyotrophic lateral sclerosis (ALS) is a multi‐system disease characterized primarily by progressive muscle weakness. Cognitive dysfunction is commonly observed in patients; however, factors influencing risk for cognitive dysfunction remain elusive. Using sparse canonical correlation analysis (sCCA), an unsupervised machine‐learning technique, we observed that single nucleotide polymorphisms collectively associate with baseline cognitive performance in a large ALS patient cohort (N = 327) from the multicenter Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium. We demonstrate that a polygenic risk score derived using sCCA relates to longitudinal cognitive decline in the same cohort and also to in vivo cortical thinning in the orbital frontal cortex, anterior cingulate cortex, lateral temporal cortex, premotor cortex, and hippocampus (N = 90) as well as post‐mortem motor cortical neuronal loss (N = 87) in independent ALS cohorts from the University of Pennsylvania Integrated Neurodegenerative Disease Biobank. Our findings suggest that common genetic polymorphisms may exert a polygenic contribution to the risk of cortical disease vulnerability and cognitive dysfunction in ALS.

Keywords